Madison Avenue Partners, LP - Q4 2022 holdings

$565 Million is the total value of Madison Avenue Partners, LP's 22 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 55.6% .

 Value Shares↓ Weighting
GHC SellGRAHAM HLDGS CO$121,074,017
+7.8%
200,384
-4.0%
21.45%
-11.0%
TBPH  THERAVANCE BIOPHARMA INC$78,677,176
+10.7%
7,012,2260.0%13.94%
-8.6%
SMCI  SUPER MICRO COMPUTER INC$75,097,773
+49.1%
914,7110.0%13.30%
+23.1%
BuyORION GROUP HLDGS INC$40,833,976
+5627.1%
4,781,496
+5767.2%
7.23%
+4628.1%
 STAGWELL INC$39,729,481
-10.6%
6,397,6620.0%7.04%
-26.2%
NewMASTERBRAND INC$34,073,3614,513,028
+100.0%
6.04%
SellSYLVAMO CORP$30,163,020
-53.8%
620,766
-67.8%
5.34%
-61.8%
GIII NewG III APPAREL GROUP LTD$25,715,6551,875,686
+100.0%
4.56%
PFSW  PFSWEB INC$18,669,310
-23.9%
2,633,1890.0%3.31%
-37.2%
NewF&G ANNUITIES & LIFE INC$18,209,500910,020
+100.0%
3.23%
NewLEONARDO DRS INC$17,507,1941,369,890
+100.0%
3.10%
FSP BuyFRANKLIN STR PPTYS CORP$13,770,191
+259.2%
5,044,026
+246.0%
2.44%
+196.4%
AIV BuyAPARTMENT INVT & MGMT COcl a$12,180,896
+442.3%
1,710,800
+456.1%
2.16%
+347.7%
 2SEVENTY BIO INC$11,242,426
-35.6%
1,199,8320.0%1.99%
-46.8%
JRVR SellJAMES RIV GROUP LTD$8,262,754
-13.2%
395,158
-5.3%
1.46%
-28.3%
OVID BuyOVID THERAPEUTICS INC$5,061,155
+97.3%
2,721,051
+95.2%
0.90%
+63.1%
PTGX NewPROTAGONIST THERAPEUTICS INC$4,435,930406,593
+100.0%
0.79%
MBI NewMBIA INC$4,259,891331,509
+100.0%
0.76%
LNSR  LENSAR INC$1,980,376
-46.7%
669,0460.0%0.35%
-56.0%
GOSS SellGOSSAMER BIO INC$1,543,256
-90.7%
711,178
-48.7%
0.27%
-92.3%
SFE  SAFEGUARD SCIENTIFICS INC$1,436,490
-16.9%
463,3840.0%0.25%
-31.5%
CEE NewCENTRAL & EASTERN EUROPE FD$578,43170,028
+100.0%
0.10%
TK ExitTEEKAY CORPORATION$0-1,041,127
-100.0%
-0.80%
SPB ExitSPECTRUM BRANDS HLDGS INC NE$0-109,142
-100.0%
-0.91%
TRQ ExitTURQUOISE HILL RES LTD$0-1,071,921
-100.0%
-6.80%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-02-14
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
GRAHAM HLDGS CO15Q3 202325.7%
SUPER MICRO COMPUTER INC13Q1 202324.2%
LENSAR INC12Q3 20231.7%
PG&E CORP10Q2 20227.5%
SAFEGUARD SCIENTIFICS INC10Q3 20231.9%
THERAVANCE BIOPHARMA INC9Q3 202316.4%
ADTALEM GLOBAL ED INC9Q1 202217.5%
STAGWELL INC9Q3 202311.4%
JAMES RIV GROUP LTD9Q2 202317.6%
PFSWEB INC9Q3 20236.3%

View Madison Avenue Partners, LP's complete holdings history.

Latest significant ownerships (13-D/G)
Madison Avenue Partners, LP Q4 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
PFSWEB INCFebruary 14, 20232,633,18911.6%
Theravance Biopharma, Inc.February 14, 20237,012,22610.4%
James River Group Holdings, Ltd.February 14, 2022794,8372.1%
Sylvamo CorpFebruary 14, 20222,090,3354.7%
LEAF GROUP LTD.May 27, 20211,767,1934.9%
MDC PARTNERS INCFebruary 16, 20213,871,4345.3%
LENSAR, Inc.February 12, 2021637,2086.0%
SUPERIOR ENERGY SERVICES INCFebruary 14, 2020793,8585.4%

View Madison Avenue Partners, LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-16
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G2024-01-22
SC 13G/A2023-12-11
13F-HR2023-11-14
13F-HR2023-08-14
SC 13G2023-07-31
13F-HR2023-05-15

View Madison Avenue Partners, LP's complete filings history.

Compare quarters

Export Madison Avenue Partners, LP's holdings